Insider Trading: Anthera Pharmaceuticals Inc (ANTH.O)
ANTH.O on Consolidated Issue listed on NASDAQ Global Market
0.61USD
17 May 2013
0.61USD
17 May 2013
Price Change (% chg)
$0.03 (+4.83%)
$0.03 (+4.83%)
Prev Close
$0.58
$0.58
Open
$0.58
$0.58
Day's High
$0.62
$0.62
Day's Low
$0.58
$0.58
Volume
623,802
623,802
Avg. Vol
789,617
789,617
52-wk High
$3.21
$3.21
52-wk Low
$0.49
$0.49
All Insider Trades
| Trading Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| 24 Mar 2013 | HISLOP COLIN |
Officer | Buy | 59,132 | $0.00 |
| 24 Mar 2013 | TRUEX PAUL F |
Chief Executive Officer | Buy | 135,644 | $0.00 |
| 24 Mar 2013 | ODINK DEBRA A |
Chief Technology Officer | Buy | 49,519 | $0.00 |
| 24 Mar 2013 | LOWE CHRISTOPHER P |
Chief Financial Officer | Buy | 67,579 | $0.00 |
| 29 Jan 2013 | ORBIMED ADVISORS L L C |
Unknown | Buy | 5,700,000 | $0.66 |
| 24 Jan 2013 | ORBIMED ADVISORS L L C |
Unknown | Buy | 1,762,000 | $0.65 |
| 9 Jan 2013 | ODINK DEBRA A |
Chief Technology Officer | Gift | 4,009 | $0.00 |
| 9 Jan 2013 | ODINK DEBRA A |
Chief Technology Officer | Gift | 4,009 | $0.00 |
| 6 Jan 2013 | TRUEX PAUL F |
Chief Executive Officer | Gift | 66,412 | $0.00 |
| 6 Jan 2013 | TRUEX PAUL F |
Chief Executive Officer | Gift | 66,412 | $0.00 |
| 2 Jan 2013 | LOWE CHRISTOPHER P |
Chairman of the Board | Sell | 8,660 | $0.69 |
| 2 Jan 2013 | ODINK DEBRA A |
Chief Technology Officer | Sell | 3,409 | $0.69 |
| 2 Jan 2013 | KILFOIL GEORGINA H |
Officer | Sell | 2,410 | $0.69 |
| 2 Jan 2013 | HISLOP COLIN |
Officer | Sell | 4,560 | $0.69 |
| 2 Jan 2013 | TRUEX PAUL F |
Chief Executive Officer | Sell | 17,454 | $0.69 |
| 29 Jun 2012 | KILFOIL GEORGINA H |
Officer | Sell | 2,068 | $0.69 |
| 29 Jun 2012 | ODINK DEBRA A |
Chief Technology Officer | Sell | 1,838 | $0.69 |
| 28 Jun 2012 | ORBIMED ADVISORS L L C |
Unknown | Sell | 1,283,300 | $0.73 |
| 28 Jun 2012 | HENNEY CHRISTOPHER S |
Director | Buy | 100,000 | $0.75 |
| 28 Jun 2012 | HENNEY CHRISTOPHER S |
Director | Buy | 100,000 | $0.75 |
| 21 Mar 2012 | ORBIMED ADVISORS L L C |
Unknown | Sell | 1,306,700 | $2.40 |
| 20 Mar 2012 | ORBIMED ADVISORS L L C |
Unknown | Sell | 125,000 | $2.87 |
| 19 Mar 2012 | ORBIMED ADVISORS L L C |
Unknown | Sell | 116,800 | $2.90 |
| 29 Feb 2012 | ODINK DEBRA A |
Chief Technology Officer | Sell | 2,000 | $6.57 |
| 22 Feb 2012 | HISLOP COLIN |
Officer | Buy | 40,000 | $0.26 |
Institutional Holders
| % Shares Owned: | 65.09% |
| # of Holders: | 52 |
| Total Shares Held: | 99,347,257 |
| 3 Mo. Net Change: | 40,784,252 |
| # New Positions: | 13 |
| # Closed Positions: | 6 |
| # Increased Positions: | 27 |
| # Reduced Positions: | 10 |
| # Net Buyers: | 17 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Christopher Henney |
72 | 2008 | Independent Chairman of the Board |
Paul Truex |
43 | 2004 | President, Chief Executive Officer, Director |
Christopher Lowe |
44 | 2011 | Chief Financial Officer, Chief Business Officer |
Debra Odink |
48 | 2011 | Senior Vice President, Chief Technology Officer |
Colin Hislop |
54 | 2010 | Senior Vice President, Chief Medical Officer |
Sanford Zweifach |
2013 | Director | |
Bogdan Dziurzynski |
64 | 2012 | Independent Director |
James Healy |
47 | 2006 | Independent Director |
Daniel Spiegelman |
54 | 2010 | Independent Director |
David Thompson |
64 | 2005 | Independent Director |
Peter Thompson |
2011 | Independent Director |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
